Organogenesis Holdings Inc (ORGO) Q4 2020 Earnings Call Tran

Organogenesis Holdings Inc (ORGO) Q4 2020 Earnings Call Transcript


Operator
Good afternoon, ladies and gentlemen, and welcome to the fourth-quarter 2020 earnings conference call for Organogenesis Holdings, Inc. [Operator instructions] Please note that this conference call is being recorded and that the recording will be available on the company's website for replay shortly. Before we begin, I would like to remind everyone that our remarks today may contain forward-looking statements that are based on the current expectations of management and involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated, including the risks and uncertainties described in the company's filings with the Securities and Exchange Commission, including Item 1A, Risk Factors, of the company's most recent annual and quarterly reports. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date today.

Related Keywords

Richard Newitter , Steven Lichtman , Dave Francisco , Matt Miksic , Gary Gillheeney , David Francisco , Ryan Zimmerman , Exchange Commission , Organogenesis Holdings Inc , Organogenesis Holdings , Organogenesis Holding , Steven Lichtman Oppenheimer Company Analyst , Perkinelmer , Credit Suisse , Risk Factors , Investor Relations , Chief Executive , Advanced Wound Care , Sports Medicine , Renu Regenerative Medicine Advanced Therapy , ஸ்டீவன் லிட்ச்மேன் , டேவ் பிரான்சிஸ்கோ , டேவிட் பிரான்சிஸ்கோ , ரியான் ஸிம்மர்மந் , பரிமாற்றம் தரகு , ஸ்டீவன் லிட்ச்மேன் ஆபெந்ஹைமர் நிறுவனம் ஆய்வாளர் , கடன் ஸ்யூயி , ஆபத்து காரணிகள் , முதலீட்டாளர் உறவுகள் , தலைமை நிர்வாகி , விளையாட்டு மருந்து ,

© 2025 Vimarsana